Crossmark

An Analysis of Drug Survival, Effectiveness, and Safety in Moderate to Severe Psoriasis Treated With Ustekinumab: An Observational Study of 69 Patients in Routine Clinical Practice

Crossref DOI link: https://doi.org/10.1016/j.adengl.2019.02.015

Published Print: 2019-04

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Salgüero Fernández, I.

Hospital Gil, M.

Sigüenza Sanz, M.

Roustan Gullón, G.
License Information

Text and Data Mining valid from 2019-04-01

Version of Record valid from 2020-09-03
More Information

This article is maintained by: Elsevier

Article Title: An Analysis of Drug Survival, Effectiveness, and Safety in Moderate to Severe Psoriasis Treated With Ustekinumab: An Observational Study of 69 Patients in Routine Clinical Practice

Journal Title: Actas Dermo-Sifiliográficas (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.adengl.2019.02.015

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.ad.2018.02.019

Content Type: simple-article

Copyright: © 2018 Elsevier España, S.L.U. and AEDV. Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below